WCLC 2024

WCLC 2024
September 07-10, 2024
San Diego, CA, USA

World Conference of Lung Cancer 2024.

Explore more information for Gilead Oncology therapies
Material Type
Filter by Keyword(s)

Filter results with keywords such as:

  • Name of author(s)
  • Disease state
  • Indication
  • Trial phase
  • Trial name
  • Trial date

Note: Multiple keywords can be applied at the same time.

    Results (3)

    Sacituzumab Govitecan as Second-Line Treatment in Patients With Extensive Stage Small Cell Lung Cancer

    • Author(s): Dowlati, A
    • trodelvy
    • Oncology
    • Oral

    Sacituzumab Govitecan vs Docetaxel in Patients With mNSCLC Non-Responsive to Last Anti-PD-(L)1- Containing Regimen: EVOKE-01

    • Author(s): Garassino, M
    • trodelvy
    • Oncology
    • Oral

    Sacituzumab Govitecan + Pembrolizumab + Carboplatin in 1L Metastatic Non-Small Cell Lung Cancer: The EVOKE-02 Study

    • Author(s): Gray, J
    • trodelvy
    • Oncology
    • Oral